Skip to main content
Kolon TissueGene, Inc. logo

Kolon TissueGene, Inc. — Investor Relations & Filings

Ticker · 950160 ISIN · KR8840120008 LEI · 5493000SYYLC88FUL781 KO Manufacturing
Filings indexed 288 across all filing types
Latest filing 2024-03-28 Declaration of Voting R…
Country US United States of America
Listing KO 950160

About Kolon TissueGene, Inc.

https://www.tissuegene.com/

Kolon TissueGene, Inc. is a clinical-stage biopharmaceutical company specializing in the development of advanced cell and gene therapies for orthopedic diseases and degenerative disorders. The company's lead product candidate, TG-C, is a first-in-class, allogeneic cell and gene therapy designed to treat knee osteoarthritis. The therapy aims to reduce pain, improve joint function, and slow the progression of the disease. TG-C is currently in late-stage clinical development, undergoing Phase 3 trials.

Recent filings

Filing Released Lang Actions
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement of the results of a General Meeting of Shareholders (정기주주총회결과) for Kolon TissueGene. It details the approval of financial statements, director appointments, and remuneration limits. This falls under the category of Declaration of Voting Results, as it reports the outcomes of shareholder votes.
2024-03-28 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act (Article 147). It details the shareholding status, changes in ownership, and the purpose of holding (management influence) by a major shareholder and their special related parties. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2024-03-27 Korean
전환청구권행사 (제1회차)
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing from Kolon TissueGene regarding the exercise of conversion rights (전환청구권행사) for convertible bonds. It details the number of shares issued upon conversion, the conversion price, and the remaining balance of convertible bonds. This type of disclosure regarding capital structure changes and share issuance falls under the 'Share Issue/Capital Change' category.
2024-03-26 Korean
[기재정정]소송등의제기ㆍ신청(일정금액이상의청구) (손해배상청구)
Legal Proceedings Report Classification · 100% confidence The document is a regulatory filing from Kolon TissueGene regarding a 'Lawsuit/Legal Proceeding' (specifically a claim for damages). It details a change in the claim amount for an existing lawsuit. Since this document pertains to significant legal proceedings and regulatory disclosure of litigation, it falls under the 'Legal Proceedings Report' category.
2024-03-20 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a regulatory filing from Kolon TissueGene titled 'Audit Report Submission' (감사보고서 제출). It provides the audit opinion, key financial data, and details regarding the audit process as required by the Korea Exchange (KRX). While it contains financial data, it is an announcement of the submission of the audit report rather than the full annual report (10-K) or a standalone audit report (AR). According to the 'Menu vs Meal' rule, since it is a short announcement regarding the filing of a report, it is classified as a Report Publication Announcement (RPA). FY 2023
2024-03-20 Korean
사업보고서 (2023.12)
Annual Report Classification · 100% confidence The document is a comprehensive 'Business Report' (사업보고서) for the fiscal year 2023 (2023.01.01-2023.12.31) filed by Kolon TissueGene, Inc. It contains detailed sections including company overview, business operations, financial information, management discussion, and governance. This structure corresponds to the standard annual financial reporting requirement for listed companies in Korea, which is equivalent to the 10-K filing in the US market. FY 2023
2024-03-20 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.